NUGL PER
¿Qué es el PER de NUGL?
El PER de NUGL, Inc. es N/A
¿Cuál es la definición de PER?
La relación precio/ganancias es la relación entre el precio de las acciones de una compañía y las ganancias por acción de la compañía calculadas en los últimos doce meses.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
PER de compañías en Sector Technology en OTC en comparadas con NUGL
¿Qué hace NUGL?
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
Empresas con per similar a NUGL
- Happy Valley Nutrition tiene PER de N/A
- Maple Peak Investments tiene PER de N/A
- co.don AG tiene PER de N/A
- BioVie tiene PER de N/A
- BioVie tiene PER de N/A
- Relmada Therapeutics tiene PER de N/A
- NUGL tiene PER de N/A
- Greencastle Resources tiene PER de N/A
- Astra Exploration Inc tiene PER de N/A
- Pharmadrug tiene PER de N/A
- Blackwolf Copper and Gold tiene PER de N/A
- Burnpur Cement tiene PER de N/A
- Exopharm tiene PER de N/A